Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: KBV Research | PRODUCT CODE: 1544268

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1544268

Global Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By End Use (Diagnostic Laboratories, Hospitals & Clinics, and Others), By Type, By Regional Outlook and Forecast, 2024 - 2031

PUBLISHED:
PAGES: 226 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 3600
PDF (Site License)
USD 4320
PDF (Enterprisewide License)
USD 6048

Add to Cart

Description

Table of Contents

List of Tables

The Global Tuberculosis Diagnostics Market size is expected to reach $3 billion by 2031, rising at a market growth of 4.7% CAGR during the forecast period.

Despite having a lower TB incidence than other regions, North America's market is driven by advanced healthcare systems, high levels of awareness, and strong public health initiatives focused on TB elimination. The U.S., in particular, has made significant investments in TB research and development, leading to the availability of cutting-edge diagnostic technologies. Consequently, the North American region would acquire nearly 30% of the total market share by 2031.

Tuberculosis (TB) continues to be a substantial global health issue, with a particularly high incidence rate in developing countries. The impact of TB is not confined to health alone; it also has significant social and economic consequences. Hence, the rising incidence of TB will increase the demand for diagnostics, thereby propelling the expansion of the market.

Additionally, this field has witnessed significant technological advancements in recent years, which have been crucial in enhancing the accuracy, speed, and accessibility of TB detection. The GeneXpert MTB/RIF assay is one of the most prominent examples of molecular diagnostics transforming TB care. Thus, these factors will aid in the growth of the market.

However, Advanced TB diagnostic tools, particularly those based on molecular diagnostics, are often priced beyond the reach of many healthcare systems in low- and middle-income countries (LMICs). The reliance on donor funding also introduces a level of uncertainty and instability in the financing of TB diagnostics. Hence, the high cost of advanced TB diagnostic tools, coupled with limited and unstable funding, presents significant barriers to the widespread adoption of these technologies.

Moreover, in order to meet the urgent needs of the pandemic, resources such as laboratory facilities, personnel, and financial allocations were redirected from tuberculosis (TB) initiatives. This was done because healthcare systems all over the world were unable to cope with the rise of COVID-19 cases. This diversion of resources led to a significant decline in TB testing and diagnosis, as many TB diagnostic facilities were repurposed for COVID-19 testing. Hence, the pandemic had an overall negative impact on the market.

End Use Outlook

On the basis of end use, the market is classified into diagnostic laboratories, hospitals & clinics, and others. The hospitals & clinics segment garnered 35% revenue share in the market in 2023. Hospitals and clinics serve as the first point of contact for many TB patients, making them critical for the initial diagnosis and treatment initiation.

Type Outlook

Based on type, the market is divided into nucleic acid testing, detection of latent infection (skin test & IGRA), detection of drug resistance (DST), phage assay, cytokine detection assay, diagnostic laboratory methods, radiographic method, and others. The phage assay segment procured 18% revenue share in the market in 2023. This method, which utilizes bacteriophages to detect TB bacteria, has gained traction due to its ability to provide quick and reliable results.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment procured a 35% revenue share in the market in 2023. The segment's growth is driven by the high burden of tuberculosis in countries such as India, China, and Indonesia. This necessitates the implementation of ubiquitous and continuous TB diagnostics, as these countries are responsible for a substantial proportion of the global TB case count.

List of Key Companies Profiled

  • Abbott Laboratories
  • Qiagen N.V
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Bruker Corporation
  • Revvity, Inc.

Global Tuberculosis Diagnostics Market Report Segmentation

By End Use

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Others

By Type

  • Detection of Latent Infection (Skin Test & IGRA)
  • Phage Assay
  • Detection of Drug Resistance (DST)
  • Nucleic Acid Testing
  • Radiographic Method
  • Cytokine Detection Assay
  • Diagnostic Laboratory Methods
  • Other Methods

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA
Show more

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Tuberculosis Diagnostics Market, by End Use
    • 1.4.2 Global Tuberculosis Diagnostics Market, by Type
    • 1.4.3 Global Tuberculosis Diagnostics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Global Tuberculosis Diagnostics Market by End Use

  • 4.1 Global Diagnostic Laboratories Market by Region
  • 4.2 Global Hospitals & Clinics Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Tuberculosis Diagnostics Market by Type

  • 5.1 Global Detection of Latent Infection (Skin Test & IGRA) Market by Region
  • 5.2 Global Phage Assay Market by Region
  • 5.3 Global Detection of Drug Resistance (DST) Market by Region
  • 5.4 Global Nucleic Acid Testing Market by Region
  • 5.5 Global Radiographic Method Market by Region
  • 5.6 Global Cytokine Detection Assay Market by Region
  • 5.7 Global Diagnostic Laboratory Methods Market by Region
  • 5.8 Global Other Methods Market by Region

Chapter 6. Global Tuberculosis Diagnostics Market by Region

  • 6.1 North America Tuberculosis Diagnostics Market
    • 6.1.1 North America Tuberculosis Diagnostics Market by End Use
      • 6.1.1.1 North America Diagnostic Laboratories Market by Country
      • 6.1.1.2 North America Hospitals & Clinics Market by Country
      • 6.1.1.3 North America Others Market by Country
    • 6.1.2 North America Tuberculosis Diagnostics Market by Type
      • 6.1.2.1 North America Detection of Latent Infection (Skin Test & IGRA) Market by Country
      • 6.1.2.2 North America Phage Assay Market by Country
      • 6.1.2.3 North America Detection of Drug Resistance (DST) Market by Country
      • 6.1.2.4 North America Nucleic Acid Testing Market by Country
      • 6.1.2.5 North America Radiographic Method Market by Country
      • 6.1.2.6 North America Cytokine Detection Assay Market by Country
      • 6.1.2.7 North America Diagnostic Laboratory Methods Market by Country
      • 6.1.2.8 North America Other Methods Market by Country
    • 6.1.3 North America Tuberculosis Diagnostics Market by Country
      • 6.1.3.1 US Tuberculosis Diagnostics Market
        • 6.1.3.1.1 US Tuberculosis Diagnostics Market by End Use
        • 6.1.3.1.2 US Tuberculosis Diagnostics Market by Type
      • 6.1.3.2 Canada Tuberculosis Diagnostics Market
        • 6.1.3.2.1 Canada Tuberculosis Diagnostics Market by End Use
        • 6.1.3.2.2 Canada Tuberculosis Diagnostics Market by Type
      • 6.1.3.3 Mexico Tuberculosis Diagnostics Market
        • 6.1.3.3.1 Mexico Tuberculosis Diagnostics Market by End Use
        • 6.1.3.3.2 Mexico Tuberculosis Diagnostics Market by Type
      • 6.1.3.4 Rest of North America Tuberculosis Diagnostics Market
        • 6.1.3.4.1 Rest of North America Tuberculosis Diagnostics Market by End Use
        • 6.1.3.4.2 Rest of North America Tuberculosis Diagnostics Market by Type
  • 6.2 Europe Tuberculosis Diagnostics Market
    • 6.2.1 Europe Tuberculosis Diagnostics Market by End Use
      • 6.2.1.1 Europe Diagnostic Laboratories Market by Country
      • 6.2.1.2 Europe Hospitals & Clinics Market by Country
      • 6.2.1.3 Europe Others Market by Country
    • 6.2.2 Europe Tuberculosis Diagnostics Market by Type
      • 6.2.2.1 Europe Detection of Latent Infection (Skin Test & IGRA) Market by Country
      • 6.2.2.2 Europe Phage Assay Market by Country
      • 6.2.2.3 Europe Detection of Drug Resistance (DST) Market by Country
      • 6.2.2.4 Europe Nucleic Acid Testing Market by Country
      • 6.2.2.5 Europe Radiographic Method Market by Country
      • 6.2.2.6 Europe Cytokine Detection Assay Market by Country
      • 6.2.2.7 Europe Diagnostic Laboratory Methods Market by Country
      • 6.2.2.8 Europe Other Methods Market by Country
    • 6.2.3 Europe Tuberculosis Diagnostics Market by Country
      • 6.2.3.1 Germany Tuberculosis Diagnostics Market
        • 6.2.3.1.1 Germany Tuberculosis Diagnostics Market by End Use
        • 6.2.3.1.2 Germany Tuberculosis Diagnostics Market by Type
      • 6.2.3.2 UK Tuberculosis Diagnostics Market
        • 6.2.3.2.1 UK Tuberculosis Diagnostics Market by End Use
        • 6.2.3.2.2 UK Tuberculosis Diagnostics Market by Type
      • 6.2.3.3 France Tuberculosis Diagnostics Market
        • 6.2.3.3.1 France Tuberculosis Diagnostics Market by End Use
        • 6.2.3.3.2 France Tuberculosis Diagnostics Market by Type
      • 6.2.3.4 Russia Tuberculosis Diagnostics Market
        • 6.2.3.4.1 Russia Tuberculosis Diagnostics Market by End Use
        • 6.2.3.4.2 Russia Tuberculosis Diagnostics Market by Type
      • 6.2.3.5 Spain Tuberculosis Diagnostics Market
        • 6.2.3.5.1 Spain Tuberculosis Diagnostics Market by End Use
        • 6.2.3.5.2 Spain Tuberculosis Diagnostics Market by Type
      • 6.2.3.6 Italy Tuberculosis Diagnostics Market
        • 6.2.3.6.1 Italy Tuberculosis Diagnostics Market by End Use
        • 6.2.3.6.2 Italy Tuberculosis Diagnostics Market by Type
      • 6.2.3.7 Rest of Europe Tuberculosis Diagnostics Market
        • 6.2.3.7.1 Rest of Europe Tuberculosis Diagnostics Market by End Use
        • 6.2.3.7.2 Rest of Europe Tuberculosis Diagnostics Market by Type
  • 6.3 Asia Pacific Tuberculosis Diagnostics Market
    • 6.3.1 Asia Pacific Tuberculosis Diagnostics Market by End Use
      • 6.3.1.1 Asia Pacific Diagnostic Laboratories Market by Country
      • 6.3.1.2 Asia Pacific Hospitals & Clinics Market by Country
      • 6.3.1.3 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Tuberculosis Diagnostics Market by Type
      • 6.3.2.1 Asia Pacific Detection of Latent Infection (Skin Test & IGRA) Market by Country
      • 6.3.2.2 Asia Pacific Phage Assay Market by Country
      • 6.3.2.3 Asia Pacific Detection of Drug Resistance (DST) Market by Country
      • 6.3.2.4 Asia Pacific Nucleic Acid Testing Market by Country
      • 6.3.2.5 Asia Pacific Radiographic Method Market by Country
      • 6.3.2.6 Asia Pacific Cytokine Detection Assay Market by Country
      • 6.3.2.7 Asia Pacific Diagnostic Laboratory Methods Market by Country
      • 6.3.2.8 Asia Pacific Other Methods Market by Country
    • 6.3.3 Asia Pacific Tuberculosis Diagnostics Market by Country
      • 6.3.3.1 China Tuberculosis Diagnostics Market
        • 6.3.3.1.1 China Tuberculosis Diagnostics Market by End Use
        • 6.3.3.1.2 China Tuberculosis Diagnostics Market by Type
      • 6.3.3.2 Japan Tuberculosis Diagnostics Market
        • 6.3.3.2.1 Japan Tuberculosis Diagnostics Market by End Use
        • 6.3.3.2.2 Japan Tuberculosis Diagnostics Market by Type
      • 6.3.3.3 India Tuberculosis Diagnostics Market
        • 6.3.3.3.1 India Tuberculosis Diagnostics Market by End Use
        • 6.3.3.3.2 India Tuberculosis Diagnostics Market by Type
      • 6.3.3.4 South Korea Tuberculosis Diagnostics Market
        • 6.3.3.4.1 South Korea Tuberculosis Diagnostics Market by End Use
        • 6.3.3.4.2 South Korea Tuberculosis Diagnostics Market by Type
      • 6.3.3.5 Singapore Tuberculosis Diagnostics Market
        • 6.3.3.5.1 Singapore Tuberculosis Diagnostics Market by End Use
        • 6.3.3.5.2 Singapore Tuberculosis Diagnostics Market by Type
      • 6.3.3.6 Malaysia Tuberculosis Diagnostics Market
        • 6.3.3.6.1 Malaysia Tuberculosis Diagnostics Market by End Use
        • 6.3.3.6.2 Malaysia Tuberculosis Diagnostics Market by Type
      • 6.3.3.7 Rest of Asia Pacific Tuberculosis Diagnostics Market
        • 6.3.3.7.1 Rest of Asia Pacific Tuberculosis Diagnostics Market by End Use
        • 6.3.3.7.2 Rest of Asia Pacific Tuberculosis Diagnostics Market by Type
  • 6.4 LAMEA Tuberculosis Diagnostics Market
    • 6.4.1 LAMEA Tuberculosis Diagnostics Market by End Use
      • 6.4.1.1 LAMEA Diagnostic Laboratories Market by Country
      • 6.4.1.2 LAMEA Hospitals & Clinics Market by Country
      • 6.4.1.3 LAMEA Others Market by Country
    • 6.4.2 LAMEA Tuberculosis Diagnostics Market by Type
      • 6.4.2.1 LAMEA Detection of Latent Infection (Skin Test & IGRA) Market by Country
      • 6.4.2.2 LAMEA Phage Assay Market by Country
      • 6.4.2.3 LAMEA Detection of Drug Resistance (DST) Market by Country
      • 6.4.2.4 LAMEA Nucleic Acid Testing Market by Country
      • 6.4.2.5 LAMEA Radiographic Method Market by Country
      • 6.4.2.6 LAMEA Cytokine Detection Assay Market by Country
      • 6.4.2.7 LAMEA Diagnostic Laboratory Methods Market by Country
      • 6.4.2.8 LAMEA Other Methods Market by Country
    • 6.4.3 LAMEA Tuberculosis Diagnostics Market by Country
      • 6.4.3.1 Brazil Tuberculosis Diagnostics Market
        • 6.4.3.1.1 Brazil Tuberculosis Diagnostics Market by End Use
        • 6.4.3.1.2 Brazil Tuberculosis Diagnostics Market by Type
      • 6.4.3.2 Argentina Tuberculosis Diagnostics Market
        • 6.4.3.2.1 Argentina Tuberculosis Diagnostics Market by End Use
        • 6.4.3.2.2 Argentina Tuberculosis Diagnostics Market by Type
      • 6.4.3.3 UAE Tuberculosis Diagnostics Market
        • 6.4.3.3.1 UAE Tuberculosis Diagnostics Market by End Use
        • 6.4.3.3.2 UAE Tuberculosis Diagnostics Market by Type
      • 6.4.3.4 Saudi Arabia Tuberculosis Diagnostics Market
        • 6.4.3.4.1 Saudi Arabia Tuberculosis Diagnostics Market by End Use
        • 6.4.3.4.2 Saudi Arabia Tuberculosis Diagnostics Market by Type
      • 6.4.3.5 South Africa Tuberculosis Diagnostics Market
        • 6.4.3.5.1 South Africa Tuberculosis Diagnostics Market by End Use
        • 6.4.3.5.2 South Africa Tuberculosis Diagnostics Market by Type
      • 6.4.3.6 Nigeria Tuberculosis Diagnostics Market
        • 6.4.3.6.1 Nigeria Tuberculosis Diagnostics Market by End Use
        • 6.4.3.6.2 Nigeria Tuberculosis Diagnostics Market by Type
      • 6.4.3.7 Rest of LAMEA Tuberculosis Diagnostics Market
        • 6.4.3.7.1 Rest of LAMEA Tuberculosis Diagnostics Market by End Use
        • 6.4.3.7.2 Rest of LAMEA Tuberculosis Diagnostics Market by Type

Chapter 7. Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 SWOT Analysis
  • 7.2 Qiagen N.V.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expenses
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Product Launches and Product Expansions:
    • 7.2.6 SWOT Analysis
  • 7.3 Thermo Fisher Scientific, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Product Launches and Product Expansions:
    • 7.3.6 SWOT Analysis
  • 7.4 Becton, Dickinson, and Company
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Partnerships, Collaborations, and Agreements:
    • 7.4.6 SWOT Analysis
  • 7.5 F. Hoffmann-La Roche Ltd.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Acquisition and Mergers:
    • 7.5.6 SWOT Analysis
  • 7.6 Hologic, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
    • 7.6.5 SWOT Analysis
  • 7.7 Danaher Corporation
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 SWOT Analysis
  • 7.8 DiaSorin S.p.A.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expenses
    • 7.8.5 SWOT Analysis
  • 7.9 Bruker Corporation
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 SWOT Analysis
  • 7.10. Revvity, Inc.
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expenses
    • 7.10.5 SWOT Analysis

Chapter 8. Winning Imperatives for Tuberculosis Diagnostics Market

Show more

LIST OF TABLES

  • TABLE 1 Global Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 2 Global Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 3 Global Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 4 Global Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 5 Global Diagnostic Laboratories Market by Region, 2020 - 2023, USD Million
  • TABLE 6 Global Diagnostic Laboratories Market by Region, 2024 - 2031, USD Million
  • TABLE 7 Global Hospitals & Clinics Market by Region, 2020 - 2023, USD Million
  • TABLE 8 Global Hospitals & Clinics Market by Region, 2024 - 2031, USD Million
  • TABLE 9 Global Others Market by Region, 2020 - 2023, USD Million
  • TABLE 10 Global Others Market by Region, 2024 - 2031, USD Million
  • TABLE 11 Global Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 12 Global Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 13 Global Detection of Latent Infection (Skin Test & IGRA) Market by Region, 2020 - 2023, USD Million
  • TABLE 14 Global Detection of Latent Infection (Skin Test & IGRA) Market by Region, 2024 - 2031, USD Million
  • TABLE 15 Global Phage Assay Market by Region, 2020 - 2023, USD Million
  • TABLE 16 Global Phage Assay Market by Region, 2024 - 2031, USD Million
  • TABLE 17 Global Detection of Drug Resistance (DST) Market by Region, 2020 - 2023, USD Million
  • TABLE 18 Global Detection of Drug Resistance (DST) Market by Region, 2024 - 2031, USD Million
  • TABLE 19 Global Nucleic Acid Testing Market by Region, 2020 - 2023, USD Million
  • TABLE 20 Global Nucleic Acid Testing Market by Region, 2024 - 2031, USD Million
  • TABLE 21 Global Radiographic Method Market by Region, 2020 - 2023, USD Million
  • TABLE 22 Global Radiographic Method Market by Region, 2024 - 2031, USD Million
  • TABLE 23 Global Cytokine Detection Assay Market by Region, 2020 - 2023, USD Million
  • TABLE 24 Global Cytokine Detection Assay Market by Region, 2024 - 2031, USD Million
  • TABLE 25 Global Diagnostic Laboratory Methods Market by Region, 2020 - 2023, USD Million
  • TABLE 26 Global Diagnostic Laboratory Methods Market by Region, 2024 - 2031, USD Million
  • TABLE 27 Global Other Methods Market by Region, 2020 - 2023, USD Million
  • TABLE 28 Global Other Methods Market by Region, 2024 - 2031, USD Million
  • TABLE 29 Global Tuberculosis Diagnostics Market by Region, 2020 - 2023, USD Million
  • TABLE 30 Global Tuberculosis Diagnostics Market by Region, 2024 - 2031, USD Million
  • TABLE 31 North America Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 32 North America Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 33 North America Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 34 North America Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 35 North America Diagnostic Laboratories Market by Country, 2020 - 2023, USD Million
  • TABLE 36 North America Diagnostic Laboratories Market by Country, 2024 - 2031, USD Million
  • TABLE 37 North America Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 38 North America Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 39 North America Others Market by Country, 2020 - 2023, USD Million
  • TABLE 40 North America Others Market by Country, 2024 - 2031, USD Million
  • TABLE 41 North America Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 42 North America Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 43 North America Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2020 - 2023, USD Million
  • TABLE 44 North America Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2024 - 2031, USD Million
  • TABLE 45 North America Phage Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 46 North America Phage Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 47 North America Detection of Drug Resistance (DST) Market by Country, 2020 - 2023, USD Million
  • TABLE 48 North America Detection of Drug Resistance (DST) Market by Country, 2024 - 2031, USD Million
  • TABLE 49 North America Nucleic Acid Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 50 North America Nucleic Acid Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 51 North America Radiographic Method Market by Country, 2020 - 2023, USD Million
  • TABLE 52 North America Radiographic Method Market by Country, 2024 - 2031, USD Million
  • TABLE 53 North America Cytokine Detection Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 54 North America Cytokine Detection Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 55 North America Diagnostic Laboratory Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 56 North America Diagnostic Laboratory Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 57 North America Other Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 58 North America Other Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 59 North America Tuberculosis Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 60 North America Tuberculosis Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 61 US Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 62 US Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 63 US Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 64 US Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 65 US Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 66 US Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 67 Canada Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 68 Canada Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 69 Canada Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 70 Canada Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 71 Canada Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 72 Canada Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 73 Mexico Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 74 Mexico Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 75 Mexico Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 76 Mexico Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 77 Mexico Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 78 Mexico Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 79 Rest of North America Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 80 Rest of North America Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 81 Rest of North America Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 82 Rest of North America Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 83 Rest of North America Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 84 Rest of North America Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 85 Europe Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 86 Europe Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 87 Europe Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 88 Europe Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 89 Europe Diagnostic Laboratories Market by Country, 2020 - 2023, USD Million
  • TABLE 90 Europe Diagnostic Laboratories Market by Country, 2024 - 2031, USD Million
  • TABLE 91 Europe Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 92 Europe Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 93 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 94 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 95 Europe Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 96 Europe Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 97 Europe Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2020 - 2023, USD Million
  • TABLE 98 Europe Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2024 - 2031, USD Million
  • TABLE 99 Europe Phage Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 100 Europe Phage Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 101 Europe Detection of Drug Resistance (DST) Market by Country, 2020 - 2023, USD Million
  • TABLE 102 Europe Detection of Drug Resistance (DST) Market by Country, 2024 - 2031, USD Million
  • TABLE 103 Europe Nucleic Acid Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 104 Europe Nucleic Acid Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 105 Europe Radiographic Method Market by Country, 2020 - 2023, USD Million
  • TABLE 106 Europe Radiographic Method Market by Country, 2024 - 2031, USD Million
  • TABLE 107 Europe Cytokine Detection Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 108 Europe Cytokine Detection Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 109 Europe Diagnostic Laboratory Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 110 Europe Diagnostic Laboratory Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 111 Europe Other Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 112 Europe Other Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 113 Europe Tuberculosis Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 114 Europe Tuberculosis Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 115 Germany Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 116 Germany Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 117 Germany Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 118 Germany Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 119 Germany Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 120 Germany Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 121 UK Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 122 UK Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 123 UK Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 124 UK Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 125 UK Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 126 UK Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 127 France Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 128 France Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 129 France Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 130 France Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 131 France Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 132 France Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 133 Russia Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 134 Russia Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 135 Russia Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 136 Russia Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 137 Russia Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 138 Russia Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 139 Spain Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 140 Spain Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 141 Spain Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 142 Spain Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 143 Spain Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 144 Spain Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 145 Italy Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 146 Italy Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 147 Italy Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 148 Italy Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 149 Italy Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 150 Italy Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 151 Rest of Europe Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 152 Rest of Europe Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 153 Rest of Europe Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 154 Rest of Europe Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 155 Rest of Europe Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 156 Rest of Europe Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 157 Asia Pacific Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 158 Asia Pacific Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 159 Asia Pacific Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 160 Asia Pacific Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 161 Asia Pacific Diagnostic Laboratories Market by Country, 2020 - 2023, USD Million
  • TABLE 162 Asia Pacific Diagnostic Laboratories Market by Country, 2024 - 2031, USD Million
  • TABLE 163 Asia Pacific Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 164 Asia Pacific Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 165 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 166 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 167 Asia Pacific Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 168 Asia Pacific Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 169 Asia Pacific Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2020 - 2023, USD Million
  • TABLE 170 Asia Pacific Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2024 - 2031, USD Million
  • TABLE 171 Asia Pacific Phage Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 172 Asia Pacific Phage Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 173 Asia Pacific Detection of Drug Resistance (DST) Market by Country, 2020 - 2023, USD Million
  • TABLE 174 Asia Pacific Detection of Drug Resistance (DST) Market by Country, 2024 - 2031, USD Million
  • TABLE 175 Asia Pacific Nucleic Acid Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 176 Asia Pacific Nucleic Acid Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 177 Asia Pacific Radiographic Method Market by Country, 2020 - 2023, USD Million
  • TABLE 178 Asia Pacific Radiographic Method Market by Country, 2024 - 2031, USD Million
  • TABLE 179 Asia Pacific Cytokine Detection Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 180 Asia Pacific Cytokine Detection Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 181 Asia Pacific Diagnostic Laboratory Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 182 Asia Pacific Diagnostic Laboratory Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 183 Asia Pacific Other Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 184 Asia Pacific Other Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 185 Asia Pacific Tuberculosis Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 186 Asia Pacific Tuberculosis Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 187 China Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 188 China Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 189 China Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 190 China Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 191 China Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 192 China Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 193 Japan Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 194 Japan Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 195 Japan Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 196 Japan Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 197 Japan Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 198 Japan Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 199 India Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 200 India Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 201 India Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 202 India Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 203 India Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 204 India Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 205 South Korea Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 206 South Korea Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 207 South Korea Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 208 South Korea Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 209 South Korea Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 210 South Korea Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 211 Singapore Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 212 Singapore Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 213 Singapore Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 214 Singapore Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 215 Singapore Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 216 Singapore Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 217 Malaysia Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 218 Malaysia Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 219 Malaysia Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 220 Malaysia Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 221 Malaysia Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 222 Malaysia Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 223 Rest of Asia Pacific Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 224 Rest of Asia Pacific Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 225 Rest of Asia Pacific Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 226 Rest of Asia Pacific Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 227 Rest of Asia Pacific Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 228 Rest of Asia Pacific Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 229 LAMEA Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 230 LAMEA Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 231 LAMEA Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 232 LAMEA Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 233 LAMEA Diagnostic Laboratories Market by Country, 2020 - 2023, USD Million
  • TABLE 234 LAMEA Diagnostic Laboratories Market by Country, 2024 - 2031, USD Million
  • TABLE 235 LAMEA Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 236 LAMEA Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 237 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 238 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 239 LAMEA Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 240 LAMEA Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 241 LAMEA Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2020 - 2023, USD Million
  • TABLE 242 LAMEA Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2024 - 2031, USD Million
  • TABLE 243 LAMEA Phage Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 244 LAMEA Phage Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 245 LAMEA Detection of Drug Resistance (DST) Market by Country, 2020 - 2023, USD Million
  • TABLE 246 LAMEA Detection of Drug Resistance (DST) Market by Country, 2024 - 2031, USD Million
  • TABLE 247 LAMEA Nucleic Acid Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 248 LAMEA Nucleic Acid Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 249 LAMEA Radiographic Method Market by Country, 2020 - 2023, USD Million
  • TABLE 250 LAMEA Radiographic Method Market by Country, 2024 - 2031, USD Million
  • TABLE 251 LAMEA Cytokine Detection Assay Market by Country, 2020 - 2023, USD Million
  • TABLE 252 LAMEA Cytokine Detection Assay Market by Country, 2024 - 2031, USD Million
  • TABLE 253 LAMEA Diagnostic Laboratory Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 254 LAMEA Diagnostic Laboratory Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 255 LAMEA Other Methods Market by Country, 2020 - 2023, USD Million
  • TABLE 256 LAMEA Other Methods Market by Country, 2024 - 2031, USD Million
  • TABLE 257 LAMEA Tuberculosis Diagnostics Market by Country, 2020 - 2023, USD Million
  • TABLE 258 LAMEA Tuberculosis Diagnostics Market by Country, 2024 - 2031, USD Million
  • TABLE 259 Brazil Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 260 Brazil Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 261 Brazil Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 262 Brazil Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 263 Brazil Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 264 Brazil Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 265 Argentina Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 266 Argentina Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 267 Argentina Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 268 Argentina Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 269 Argentina Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 270 Argentina Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 271 UAE Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 272 UAE Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 273 UAE Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 274 UAE Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 275 UAE Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 276 UAE Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 277 Saudi Arabia Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 278 Saudi Arabia Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 279 Saudi Arabia Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 280 Saudi Arabia Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 281 Saudi Arabia Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 282 Saudi Arabia Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 283 South Africa Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 284 South Africa Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 285 South Africa Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 286 South Africa Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 287 South Africa Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 288 South Africa Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 289 Nigeria Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 290 Nigeria Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 291 Nigeria Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 292 Nigeria Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 293 Nigeria Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 294 Nigeria Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 295 Rest of LAMEA Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
  • TABLE 296 Rest of LAMEA Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
  • TABLE 297 Rest of LAMEA Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
  • TABLE 298 Rest of LAMEA Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
  • TABLE 299 Rest of LAMEA Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
  • TABLE 300 Rest of LAMEA Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
  • TABLE 301 Key Information - Abbott Laboratories
  • TABLE 302 Key Information - Qiagen N.V.
  • TABLE 303 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 304 Key Information - Becton, Dickinson and Company
  • TABLE 305 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 306 Key Information - Hologic, Inc.
  • TABLE 307 Key Information - Danaher Corporation
  • TABLE 308 Key Information - DiaSorin S.p.A.
  • TABLE 309 Key Information - Bruker Corporation
  • TABLE 310 Key Information - Revvity, Inc.
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!